. Nevertheless, toxicity of those very efficient PKC agonists is an ongoing problem, in addition to requirement to deliver the prescription drugs by way of injection. Presently, synthetic analogs of bryostatin58,59 and prostratin60 are increasingly being explored, with minimized toxicity and cost of synthesis as opposed with their normal resource https://joanj905ajj3.wikidirective.com/user